CoA vows to audit Health department’s COVID vaccine purchases

THE COMMISSION on Audit’s (CoA) chairman, whose nomination was confirmed on Wednesday, vowed to audit coronavirus vaccine purchases of the Health department. The agency is not bound by confidentiality agreements signed by the Department of Health (DoH) and vaccine suppliers, national auditor Gamaliel A. Cordoba told lawmakers of the Commission on Appointments. “We will demand […]

InaVac gets emergency approval from BPOM

Surabaya, East Java, Indonesia, Nov 14, 2022 – (ACN Newswire via SEAPRWire.com) – The Food and Drug Supervisory Agency (BPOM) has issued emergency use authorization (EUA) for InaVac, a COVID-19 vaccine developed by researchers from Airlangga University (Unair). InaVac, COVID-19 vaccine, is developed by the University of Airlangga in Surabaya, East Java Province. (ANTARA/HO-BPBRIN Unair) […]

Ministry of Health, Labour and Welfare in Japan Approves Partial Change to a New Drug Authorization for Moderna’s Omicron-Targeting Bivalent Booster COVID-19 Vaccine, mRNA-1273.222

EQS Newswire / 01/11/2022 / 04:21 EST/EDT Ministry of Health, Labour and Welfare in Japan Approves Partial Change to a New Drug Authorization for Moderna’s Omicron-Targeting Bivalent Booster COVID-19 Vaccine, mRNA-1273.222 CAMBRIDGE, MA / ACCESSWIRE / November 1, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]

AIM Vaccine Announces Global Offering Results, Offer Price of HK$16.16 per H Share

HONG KONG, Oct 5, 2022 – (ACN Newswire via SEAPRWire.com) – AIM Vaccine Co., Ltd. (“AIM Vaccine” or the “Company”, together with its subsidiaries, the “Group”, stock code: 06660.HK), the second largest vaccine company in China in terms of 2021 approved lot release volume (excluding COVID-19 vaccines), today announced the allotment results of its Global […]

Bio Farma secures multi-year Purchase Contract from UNICEF for its novel Oral Polio Vaccine type 2 (nOPV2)

BANDUNG, INDONESIA, Oct 2, 2022 – (ACN Newswire via SEAPRWire.com) – PT Bio Farma (Persero), the holding company for pharmaceutical state-owned enterprises (SOEs), will export its novel Oral Polio Vaccine type 2 (nOPV2) having secured a purchase contract with the United Nations Children’s Fund (UNICEF) for 2022 & 23. Under the contract, Bio Farma will […]

AIM Vaccine Announces Proposed Listing on the Main Board of SEHK

HONG KONG, Sep 23, 2022 – (ACN Newswire via SEAPRWire.com) – AIM Vaccine Co., Ltd. (“AIM Vaccine” or the “Company”, together with its subsidiaries, the “Group”, stock code: 06660.HK), the second largest vaccine company in China in terms of 2021 approved lot release volume (excluding COVID-19 vaccines), announced the proposed listing of its H shares […]

Indonesia’s Bio Farma ready to produce ‘IndoVac’ Covid-19 vaccines

BANDUNG, INDONESIA, Sep 12, 2022 – (ACN Newswire via SEAPRWire.com) – PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in manufacturing IndoVac, its Covid-19 vaccines brand, including primary series vaccines, booster vaccines and vaccines for children, in development since November 2021. IndoVac Covid-19 vaccine in production at […]

Indonesian pharmaceutical Bio Farma ready to produce IndoVac Covid-19 vaccines

Bandung, W Java, Indonesia, Sep 9, 2022 – (ACN Newswire via SEAPRWire.com) – PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in the manufacturing of IndoVac, a Covid-19 vaccine brand it has developed since November 2021. IndoVac Covid-19 vaccine in production at PT Bio Farma’s facilities near […]

Moderna Reviews Clinical Trial Programs Across Portfolio at 2022 R&D Day

EQS Newswire / 08/09/2022 / 23:42 EST/EDT Moderna Reviews Clinical Trial Programs Across Portfolio at 2022 R&D Day Interim data from Phase 1/2 propionic acidemia (PA) multi-dose Paramount trial shows mRNA-3927 was well-tolerated to date, with encouraging early signs of potential for clinical benefit Interim data from Phase 1/2 glycogen storage disease 1a (GSD1a) single-dose […]

AstraZeneca nixes variant-specific COVID vaccines, eyes annual shots 

There is little value in developing vaccines that target specific coronavirus variants, according to Bruce Mungall, Asia area medical director of vaccines and infectious diseases at AstraZeneca, a multinational pharmaceutical company.   “In terms of whether there’s value in chasing a new updated vaccine for a specific variant, I think there’s very limited incremental value in […]

Preparing for monkeypox

The World Health Organization (WHO) recently declared the escalating global monkeypox outbreak a Public Health Emergency of International Concern (PHEIC).  According to the WHO, there are now more than 19,000 reported cases from 78 countries and territories.  On July 29, the Department of Health (DoH) reported the first case of monkeypox in the country — […]

Twenty million lives

In the first year of global vaccination programs, close to 20 million out of a potential 31 million coronavirus disease 2019 (COVID-19) deaths were prevented worldwide, according to a study.  Researchers from the Imperial College London MRC Centre for Global Infectious Disease Analysis estimated the impact of global vaccination programs by using an established model […]

MegaPro Successfully Completes the biological evaluations of IOP as Vaccine Adjuvant T cell mediated Immunity is Substantially Enhanced, Improving the Efficacy of Vaccines

EQS Newswire / 26/07/2022 / 10:41 UTC+8 MegaPro Biomedical (6827) Successfully Completed IOP Vaccine Adjuvant Cell Experiment Press Release   MegaPro Successfully Completes the biological evaluations of IOP as Vaccine Adjuvant T cell mediated Immunity is Substantially Enhanced, Improving the Efficacy of Vaccines    MegaPro Biomedical Co., Ltd.  (hereinafter referred to as “MegaPro”, Taiwan OTC […]

Therapeutic Goods Administration Grants Provisional Approval for Moderna’s COVID-19 Vaccine in Children Aged Six Months to Five Years

Cambridge, MA, Jul 19, 2022 – (ACN Newswire via SEAPRWire.com) – Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Therapeutic Goods Administration (TGA) in Australia has granted provisional registration for the use of Moderna’s mRNA COVID-19 vaccine, Spikevax, in a two-dose series of 25 ug per […]

Novotech Client SK bioscience Achieves SKYCovione(TM) COVID-19 Vaccine Approval in Korea

SEOUL, S.KOREA, Jul 13, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, congratulates its client SK bioscience on the recent COVID-19 vaccine licence approval. SK bioscience and GSK recently announced the successful authorization: SK bioscience announced that ‘SKYCovione(TM),’ South […]